Amalgamated Bank Kinnate Biopharma Inc. Transaction History

Amalgamated Bank

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	SELL	$3.46 - $7.98 $2,342 - $5,402	-677 Reduced 18.23%	3,037 $19,000
Q2 2022 Aug 15, 2022	BUY	$7.43 - $13.0 $4,027 - $7,046	542 Added 17.09%	3,714 $47,000
Q1 2022 Jun 30, 2022	BUY	$7.73 - $17.99 $24,519 - $57,064	3,172 New	3,172 $36,000

292K

Ticker KNTE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,145,600
Description
Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors; ...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.